Prednisolone Pharmacokinetics and Pharmacodynamics in Relation to Sex and Race

Prednisolone pharmacokinetics (PK) and pharmacyodynamics (PD) were investigated in relation to sex and race in white males, black males, white females, and black females (n = 8/group) after a single oral dose (0.27 mg/kg) of prednisone. The study consisted of baseline and prednisone phases with 32‐hour sampling in each phase. Women were studied during the luteal phase of their menstrual cycle. Total and free plasma prednisolone concentrations were assayed by HPLC and ultrafiltration, and pharmacokinetic data were analyzed by compartmental fitting using WinNonlin. Plasma cortisol concentrations were assayed by HPLC; T‐helper, T‐suppressor lymphocyte, and neutrophil cell counts were determined by FACS and hemocytometry, and these pharmacodynamic data were evaluated by basic and extended indirect response models using ADAPT II. Total body weight‐normalized free prednisolone oral clearance and apparent volume of distribution were higher in men compared with women, regardless of race (by 22% in whites and 40% in blacks for oral clearance, p < 0.01; by 32% in whites and 38% in blacks for apparent volume of distribution, p < 0.01). The 50% inhibitory concentration (IC50) values for T‐suppressor cell‐trafficking inhibition were higher in whites than in blacks, regardless of sex (by 125% in men and 208% in women, p < 0.01). The IC50 or SC50 values for effects of prednisolone on cortisol secretion and T‐helper lymphocyte or neutrophil trafficking were not statistically different between men and women, blacks and whites. The findings of this study suggest that there are some prednisolone PK/PD differences related to sex and race. However, these differences do not suggest the need for dosage adjustments, and additional experiments with repeat dosing are needed to fully evaluate the clinical implication of these findings.

[1]  J. Johnson,et al.  Influence of race or ethnicity on pharmacokinetics of drugs. , 1997, Journal of pharmaceutical sciences.

[2]  H. Moldofsky,et al.  Diurnal sleep/wake‐related immune functions during the menstrual cycle of healthy young women , 1995, Journal of sleep research.

[3]  J. Alexander,et al.  Causes of renal allograft loss in black vs. white transplant recipients in the cyclosporine era. , 1997, Clinical transplantation.

[4]  P. Meffin,et al.  Alterations in prednisolone disposition as a result of time of administration, gender and dose. , 1984, British journal of clinical pharmacology.

[5]  A. Fauci,et al.  Glucocorticosteroid therapy: mechanisms of action and clinical considerations. , 1976, Annals of internal medicine.

[6]  S. Yong,et al.  Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes. , 1984, Clinical immunology and immunopathology.

[7]  W. Jusko,et al.  Prednisolone binding to albumin and transcortin in the presence of cortisol. , 1982, Biochemical pharmacology.

[8]  J. P. Singh,et al.  Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients. , 1995, Transplantation.

[9]  R. Freedman,et al.  Sex Differences in Peripheral Vascular Adrenergic Receptors , 1987, Circulation research.

[10]  E. Schuetz,et al.  Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. , 1995, The Journal of pharmacology and experimental therapeutics.

[11]  D. Dubey,et al.  Increased PGE2 from human monocytes isolated in the luteal phase of the menstrual cycle. Implications for immunity? , 1994, Prostaglandins.

[12]  F. G. McDonald,et al.  Variation in natural killer activity in peripheral blood during the menstrual cycle. , 1985, British medical journal.

[13]  H. Saitoh,et al.  Different absorption behaviors among steroid hormones due to possible interaction with P-glycoprotein in the rat small intestine. , 1999, Biological & pharmaceutical bulletin.

[14]  J L Brazier,et al.  Pharmacokinetics of caffeine during and after pregnancy. , 1983, Developmental pharmacology and therapeutics.

[15]  J. Witte,et al.  CYP3A activity in African American and European American men: Population differences and functional effect of the CYP3A4*1B 5′‐promoter region polymorphism , 2000, Clinical pharmacology and therapeutics.

[16]  J. Carmody,et al.  Experimental Pain in Healthy Human Subjects: Gender Differences in Nociception and in Response to Ibuprofen , 1998, Anesthesia and analgesia.

[17]  W J Jusko,et al.  Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena. , 1998, Journal of pharmaceutical sciences.

[18]  W. Jusko,et al.  Prednisolone disposition and protein binding in oral contraceptive users. , 1983, The Journal of clinical endocrinology and metabolism.

[19]  H. Saitoh,et al.  Defferent Absorption Behaviors among Steroid Hormones Due to Possible Interaction with P-Glycoprotein in the Rat Small Intestine , 1999 .

[20]  M. Lehmann,et al.  Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. , 1993, JAMA.

[21]  J. Schwartz,et al.  Aging of women alters S‐verapamil pharmacokinetics and pharmacodynamics , 1994, Clinical pharmacology and therapeutics.

[22]  W. Jusko,et al.  Pharmacoimmunodynamic interactions of interleukin‐10 and prednisone in healthy volunteers , 1999, Clinical pharmacology and therapeutics.

[23]  W. Jusko,et al.  Gender‐based effects on methylprednisolone pharmacokinetics and pharmacodynamics , 1993, Clinical pharmacology and therapeutics.

[24]  W J Jusko,et al.  Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects , 1989, Clinical pharmacology and therapeutics.

[25]  R. Horst,et al.  Regulation of L‐selectin and CD18 on bovine neutrophils by glucocorticoids: effects of cortisol and dexamethasone , 1995, Journal of leukocyte biology.

[26]  M. Polan,et al.  Cultured human luteal peripheral monocytes secrete increased levels of interleukin-1. , 1990, The Journal of clinical endocrinology and metabolism.

[27]  E. Bloemena,et al.  The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo , 1990, Clinical and experimental immunology.

[28]  W. Jusko,et al.  Corticosteroid analysis in biological fluids by high-performance liquid chromatography. , 1979, Journal of chromatography.

[29]  J. Neylan.  Immunosuppressive Therapy In High-risk Transplant Patients: Dose-dependent Efficacy Of Mycophenolate Mofetil In African-american Renal Allograft Recipients1 , 1997 .

[30]  W. Jusko,et al.  Pharmacokinetic and Adrenal Interactions of IL‐10 and Prednisone in Healthy Volunteers , 1999, Journal of clinical pharmacology.

[31]  A. Kashuba,et al.  Physiological Changes During the Menstrual Cycle and Their Effects on the Pharmacokinetics and Pharmacodynamics of Drugs , 1998, Clinical pharmacokinetics.

[32]  T. Miyawaki,et al.  Circadian changes of T lymphocyte subsets in human peripheral blood. , 1984, Clinical and experimental immunology.

[33]  J. Neylan.  Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. , 1997, Transplantation.

[34]  J. Goust,et al.  Cyclic variations in white cell subpopulations in the human menstrual cycle: correlations with progesterone and estradiol. , 1979, Clinical immunology and immunopathology.

[35]  F. Frey,et al.  Urinary 6 beta-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism. , 1983, The Journal of laboratory and clinical medicine.

[36]  S. Ansar Ahmed,et al.  Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. , 1985, The American journal of pathology.

[37]  N. Pyszczynski,et al.  Fifteen years of operation of a high-performance liquid chromatographic assay for prednisolone, cortisol and prednisone in plasma. , 1994, Journal of chromatography. B, Biomedical applications.

[38]  Honghao Zhou,et al.  Ethnic Differences in Drug Disposition and Responsiveness , 1991, Clinical pharmacokinetics.

[39]  W. Jusko,et al.  ALGORITHM FOR APPLICATION OF FOURIER ANALYSIS FOR BIORHYTHMIC BASELINES OF PHARMACODYNAMIC INDIRECT RESPONSE MODELS , 2000, Chronobiology international.

[40]  R. Venuto,et al.  Racial Differences in the Pharmacokinetics of Methylprednisolone in Black and White Renal Transplant Recipients , 1993, Pharmacotherapy.